Eurocine and Redbiotec partner to develop HSV-2 vaccines
Redbiotec is entitled to receive royalty payments on Eurocine’s net sales of an approved HSV-2 vaccine.
Deals
Latest in
Deals
Evgen Pharma and University of Michigan to study colorectal cancer asset
The parties will assess the in vivo effects of SFX-01 in models of colorectal cancer.
Coave and ABL partner to develop gene therapy manufacturing processes
The process development teams of the companies will work together in a GMP facility of ABL in Lyon, France.
Pfizer acquires biopharma firm ReViral for up to $525m
Pfizer will gain rights to ReViral’s portfolio of therapeutic candidates, including sisunatovir.
Debt offerings decreased significantly in the pharmaceutical industry in H2 2021
Debt offerings in the pharma sector have seen a decrease of 34.7% from H2 2020 to H2 2021, an analysis…
By
Mineralys raises $118m to advance hypertension therapy development
Top-line data from Phase II Target-HTN trial of MLS-101 in patients with uncontrolled hypertension is expected this year.
Integral Molecular and Optimeos partner to develop gene therapies
The alliance will merge Integral Molecular’s antibody discovery and mRNA immunisation expertise with Optimeos’ technology.
Catalent, MigVax enter deal to develop tablet vaccine for Covid-19
Zydis technology produces a freeze-dried tablet that dissolves quickly in the mouth without needing water.